Atlas Trials

A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass

Clinical trial NCT04615910 · UNKNOWN

Trial details

NCT number
NCT04615910
Sponsor
Radboud University Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2021-07-01
Primary completion
2025-04-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.